Tempe, AZ, February 13, 2019 – SDC is excited to announce that Dale W. Usner, Ph.D., Chief Scientific Officer (CSO) and Senior Vice President, Strategic Scientific Consulting at SDC, co-authored the article “Long-term Safety and Ocular Hypotensive Efficacy Evaluation of Netarsudil Ophthalmic Solution: Rho Kinase Elevated IOP Treatment Trial (ROCKET-2)” published in the American Journal of Ophthalmology.
For online access the full article, please visit https://authors.elsevier.com/c/1YYyAgnZ2n4P.
SDC delivers top-tier clinical trial services to pharmaceutical, biologic, and medical device/diagnostic companies since 2005. We are committed to providing experienced teams who will take ownership of your needs and are positively engaged in your projects. With strategic scientific consulting and clinical data services (biostatistics, data management/EDC, and IRT/IWRS) expertise at our core, our services are scalable via our diverse and complementary strategic partnerships to provide full service clinical trial solutions. Speak with us today to see why SDC is The Right Fit For You.